Experimental therapy stopped the metastasis of breast and ovarian cancers in lab mice, pointing toward a safe and effective alternative to chemotherapy.
A team of Stanford researchers has developed a protein therapy that disrupts the process that causes cancer cells to break away from original tumor sites, travel through the bloodstream and start aggressive new growths elsewhere in the body.
This process, known as metastasis, can cause cancer to spread with deadly effect.
“The majority of patients who succumb to cancer fall prey to metastatic forms of the disease,” said Jennifer Cochran, an associate professor of bioengineering who describes a new therapeutic approach in Nature Chemical Biology.
Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects.
The Stanford team seeks to stop metastasis, without side effects, by preventing two proteins – Axl and Gas6 – from interacting to initiate the spread of cancer.
Axl proteins stand like bristles on the surface of cancer cells, poised to receive biochemical signals from Gas6 proteins.
When two Gas6 proteins link with two Axls, the signals that are generated enable cancer cells to leave the original tumor site, migrate to other parts of the body and form new cancer nodules.
To stop this process Cochran used protein engineering to create a harmless version of Axl that acts like a decoy. This decoy Axl latches on to Gas6 proteins in the bloodstream and prevents them from linking with and activating the Axls present on cancer cells.
In collaboration with Professor Amato Giaccia, who leads the Radiation Biology Program in the Stanford Cancer Center, the researchers gave intravenous treatments of this bioengineered decoy protein to mice with aggressive breast and ovarian cancers.
Mice in the breast cancer treatment group had 78 percent fewer metastatic nodules than untreated mice. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein.
“This is a very promising therapy that appears to be effective and nontoxic in preclinical experiments,” Giaccia said. “It could open up a new approach to cancer treatment.”
The Latest on: Alternative to chemotherapy
via Google News
The Latest on: Alternative to chemotherapy
- Teacher Undergoing Chemotherapy for Stage IV Cancer Continues Working from Hospital amid Pandemicon May 8, 2020 at 5:33 pm
Wil Loesel never expected that his first year of teaching would be disrupted by a global pandemic and a cancer diagnosis. But unfortunately, that was the situation in which the eighth-grade Charlotte ...
- I’m riding on the wings of angels to get through new cancer treatment in lockdownon May 8, 2020 at 5:57 am
CANCER isn’t going anywhere, just because Covid has turned up. My cancer has decided to throw me new challenges mid-pandemic – in the shape of radiotherapy. ⚠️ Read our coronavirus ...
- Mind jumble: Understanding chemo brainon May 6, 2020 at 6:14 am
Sarah Liu was treated for leukemia as a teenager. She attended her high school graduation on a four-hour pass from Lucile Packard Children's Hospital Stanford and was bald under her white graduation ...
- A new compound removes senescent cells and reduces toxicity in cancer treatmenton May 5, 2020 at 6:33 am
Senescence is a response to cell damage and stress characterized by the arrest of the cell cycle. When aging, cells permanently stop dividing, thus preventing the propagation of damaged and ...
- Teen given three months to live after being diagnosed with rare cancer has treatment suspended due to coronaviruson May 3, 2020 at 2:14 pm
A TEENAGE lad initially given three months to live after being diagnosed with a rare cancer has had treatment stopped due to coronavirus. Alfie Keogh, 19, was found to have Spindle Cell Synovial ...
- DNA methylation of chronic lymphocytic leukemia with differential response to chemotherapyon May 1, 2020 at 2:11 am
Measurement(s) DNA methylation Technology Type(s) methylation profiling by array Factor Type(s) TP53 mutation status • response to fludarabine or bendamustine • chromosomal aberration • IGHV mutation ...
- 'Open for business': Message to cancer patients after drop in chemotherapy appointmentson April 30, 2020 at 1:21 am
Thousands of people newly diagnosed with cancer could die within a year as a result of the coronavirus pandemic, according to a study from University College London.
- Cancer Diagnosis and Treatment Upended by COVID-19, Says CRUKon April 28, 2020 at 9:43 am
The pandemic has severely affected cancer screening, diagnosis, and treatment, resulting in patients being undiagnosed and untreated, warns Cancer Research UK.
- The 3,800 Club: One year since I started chemo, and so much has changedon April 24, 2020 at 8:00 am
VANCOUVER -- Has it really been a year? A year since I began chemotherapy for breast cancer? A year since I first felt the unrelenting nausea from treatment and then the loss of my hair?
- FDA approves another chemotherapy alternative for aggressive form of breast canceron April 23, 2020 at 7:02 am
As of Wednesday, there’s an FDA-approved treatment option besides chemotherapy for people with triple-negative breast cancer that has spread to other parts of the body.
via Bing News